Get the latest news, insights, and market updates on TNDM (Tandem Diabetes Care, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Tandem Diabetes Care Q4 Earnings Call Highlights
Tandem Diabetes Care (NASDAQ:TNDM) reported record fourth-quarter and full-year 2025 results while outlining a major shift in its U.S. reimbursement strategy that management said will reshape growth and profitability over time. Executives described 2025 as a “defining year,” highlighted by surpassin Feb 20, 2026 - $TNDM
Tandem Diabetes’s (NASDAQ:TNDM) Q4 CY2025 Sales Top Estimates
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 15% year on year to $290.4 million. Its GAAP loss of $0.01 per share was 84.4% above analysts’ consensus estimates. Feb 19, 2026 - $TNDM
Tandem Diabetes Care (TNDM) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Tandem Diabetes Care (TNDM) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. Feb 19, 2026 - $TNDM
Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Weakness
Why Tandem Diabetes Care Stock Is Back on Investors’ Radar Tandem Diabetes Care (TNDM) shares have been under pressure recently, with a negative move over the past month and year. This is prompting some investors to reassess how the current price lines up with fundamentals. See our latest analysis for Tandem Diabetes Care. At the current share price of $18.84, Tandem Diabetes Care has seen a 6.55% 1 month share price decline and a 42.24% 1 year total shareholder return decline. This suggests... Feb 18, 2026 - $TNDM
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 We Question
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts. Feb 16, 2026 - $TNDM
Tandem Diabetes Care Announces Upcoming Conference Presentations
SAN DIEGO, February 12, 2026--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: Feb 12, 2026 - $TNDM
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple